BT5528

Bicycle Therapeutics announces first patient dosed in phase I dose escalation of BT5528 in combination with nivolumab
Pharmaceutical Business Review
Wed, 05/6/20 - 12:10 pm
Bicycle Therapeutics
clinical trials
BT5528
nivolumab